Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,130.00
(
0.48%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.07
(
-0.58%
)
Bitcoin
74,007.63
(
0.09%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: oc631 post# 109567

Sunday, 11/28/2010 7:34:15 PM

Sunday, November 28, 2010 7:34:15 PM

Post# of 257253
Portola’s approach to Lovenox reversal is not materially different from PYMX’s. Both companies’ compounds block LMWHs such as Lovenox from binding to antithrombin, which makes LMWH unable to inhibit FXa. Please see #msg-26898084 for a pictorial on the interaction of LMWH and antithrombin (shown as ATIII).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up